U.S. market Closed. Opens in 11 hours 17 minutes

RXST | RxSight, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for RXST we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is bad and Health is strong.

Valuation (5%)

Company Industry
P/E Ratio (TTM) -52.55 48.15
PEG Ratio (TTM) -2.76 -0.75
P/S Ratio (TTM) 16.13 6.09
P/B Ratio (TTM) 7.02 6.11
P/FCF Ratio (TTM) -53.86 41.92
Price to 5YR AVG Earnings Ratio N/A 59.76
Price to 5YR AVG FCF Ratio N/A 34.06

Profitability (0%)

Company Industry
ROA (TTM) -12.04% 5.34%
ROE (TTM) -19.33% 27.86%
Net Profit Margin (TTM) -29.74% 7.75%
ROIC 5YR AVG N/A 6.80%

Growth (42%)

4QTR AVG 3YR AVG 5YR AVG
EPS 19.52% -568.70% N/A
Revenue 15.51% 241.93% N/A
Net Income 17.55% -130.61% N/A
Cash Flow 8.02% -15.10% N/A

Health (67%)

Company Industry
Current Ratio (TTM) 14.33 2.88
Quick Ratio (TTM) 13.34 2.16
D/E Ratio (TTM) 0.04 0.62
Interest Coverage (TTM) 197.98 23.68
Piotroski F-Score 5 6
Altman Z-Score 37.74 7.61
LTL to 5YR AVG FCF N/A 3.48
Shares Outstanding Growth 5YR AVG N/A 1.64%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙